MISSION VIEJO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Human Appeal joins the wider humanitarian community in welcoming the recently…
Milestone strengthens the company’s leadership in advanced IOL innovationFINEVISION HP, with millions of implantations worldwide, will now be available to…
Greater than 90% depletion of B cells within 12 hours of a single dose of AAN-14xMultiple redosing of AAN-14x at…
- Petosemtamab in combination with FOLFOX /FOLFIRI (1L and 2L mCRC) and as monotherapy (3L+ mCRC), demonstrates antitumor activity and…
SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the design and…
– Deal to add navenibart, a late-stage and long-acting plasma kallikrein inhibitor, in Phase 3 clinical development, to BioCryst’s HAE…
Distinguished cancer leader to advise BPGbio leadership on acceleration of NAi platform globally and BPM 31510 oncology franchise for Precision…
Non-inferiority trial versus PAXLOVID® assessing safety and efficacy, including rates of disease rebound and incidence of Long COVID development, of…
SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to…
The FDA-approved wearable offers a drug-free, safe solution for treating nasal congestion and allergies.SAN FRANCISCO--(BUSINESS WIRE)--SoundHealth is proud to announce…